相关实验视频
Updated: Jul 24, 2025

08:09
A Doxorubicin-induced Cardiomyopathy Model in Adult Zebrafish
Published on: June 7, 2018
9.8K
布拉迪基宁受体通过调节iNOS信号通路来参与多克索鲁比辛诱导的心脏毒性
Xueyan Chen1,2, Kerang Xie3, Xiaofei Zhang1,2
1The Key Laboratory of Neural and Vascular Biology, Ministry of Education, Hebei Medical University, Shijiazhuang, P. R. China.
Journal of biochemical and molecular toxicology
|July 6, 2023
概括
多克索鲁比 (DOX) 导致心脏损伤,但阻断布拉迪基宁 (BK) 受体可以防止这种损伤. 这表明BK受体和iNOS信号是DOX心脏毒性的关键.
科学领域:
- 心脏病学 心脏病学
- 药理学 药理学是指药理学的学科.
- 分子生物学分子生物学
背景情况:
- 多克索鲁比 (DOX) 是一种重要的化疗药物,但会引起剂量依赖的心脏毒性.
- 造成DOX诱导心脏毒性的分子机制尚不清楚.
- 布拉迪基宁 (BK) 受体与心血管功能有关.
研究的目的:
- 为了研究BK受体在DOX诱导心脏毒性的作用.
- 阐明涉及BK受体和iNOS信号的潜在分子机制.
主要方法:
- 使用了BK受体B1/B2双击 (B1B2-/-) 的小鼠.
- 给野生型和B1B2-/-型小鼠使用DOX.
- 评估了心肌损伤标志物 (血清AST,CK,LDH).
- 测量了布拉迪基宁B1/B2受体,FABP4,iNOS和eNOS的组织表达.
主要成果:
- 在野生型小鼠中,DOX诱导了心肌损伤,血清酶升高和组织蛋白质表达改变.
- 这些DOX诱导的影响在B1B2-/-小鼠中显著减弱.
- BK受体激活和iNOS上调与DOX心脏毒性有关.
结论:
- BK B1和B2受体的激活有助于DOX诱导的急性心肌损伤.
- iNOS信号通路可能参与通过BK受体调解DOX心脏毒性.
相关概念视频
Heart Failure Drugs: Inotropic Agents
635
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
635
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
467
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
467
The Intrinsic Apoptotic Pathway
6.6K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.6K
Transducer Mechanism: Enzyme-Linked Receptors
2.5K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.5K
Intracellular Signaling Affects Focal Adhesions
2.7K
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Some...
2.7K
Antihypertensive Drugs: Angiotensin II Receptor Blockers
786
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
786

